Insider Trading March 2, 2026

InfuSystem CFO Buys $18,906 in Stock; Shares Rise After Q4 EPS Beat

Executive vice president increases stake as company posts a better-than-expected quarterly profit per share but narrowly misses revenue estimates

By Avery Klein INFU
InfuSystem CFO Buys $18,906 in Stock; Shares Rise After Q4 EPS Beat
INFU

InfuSystem Holdings' Executive Vice President and CFO Barry G. Steele purchased 2,064 shares on March 2, 2026, at $9.16 per share, a $18,906 investment that followed a subsequent rise in the stock to $9.29. The insider transaction brings Steele's direct holdings to 88,000 shares. Separately, the company posted fourth-quarter 2025 earnings that beat EPS expectations while falling slightly short on revenue. An analysis referenced in the filing notes a low PEG ratio, and additional research tips are available for investors seeking more depth.

Key Points

  • CFO Barry G. Steele bought 2,064 shares on March 2, 2026 at $9.16 per share, totaling $18,906.
  • After the purchase the stock traded up to $9.29, representing roughly an 8% gain over the prior week.
  • InfuSystem’s Q4 2025 EPS was $0.10, beating the $0.07 estimate by 42.86%, while revenue of $36.2 million slightly missed the $36.68 million expectation.

Barry G. Steele, who serves as Executive Vice President and Chief Financial Officer of InfuSystem Holdings, Inc. (NYSE:INFU), executed a purchase of 2,064 shares of the company’s common stock on March 2, 2026. The shares were acquired at $9.16 apiece, for a total outlay of $18,906.

In the days following the transaction the share price rose to $9.29. The company’s stock performance since the purchase has reflected an approximate 8% return over the past week, as reported.

Following this buy, Steele holds 88,000 shares directly. That total includes a more recent addition of 1,359 shares obtained through the company’s Employee Stock Purchase Plan. The filing that documents the transaction notes these holdings without further comment.

The disclosure also references an analysis from InvestingPro that characterizes the stock as undervalued, citing a PEG ratio of 0.16. The same note points investors toward 11 additional tips available through that service for those seeking further information about INFU.


Separately, InfuSystem released its fourth-quarter 2025 results. The company reported earnings per share of $0.10, topping the consensus estimate of $0.07 and representing a 42.86% surprise to the upside. Revenue for the quarter was reported at $36.2 million, slightly below the expected $36.68 million.

Despite the revenue shortfall, the market reaction to the earnings release has been positive, with the stock showing upward movement in the wake of the report. The corporate filings and market responses cited here comprise the recent updates regarding InfuSystem Holdings.

Investors and observers should note that the reporting includes the internal purchase details, the valuation metric highlighted by InvestingPro, and the company’s quarterly results as the core items disclosed in the recent public filings and announcements.

Risks

  • Revenue came in marginally below expectations - a potential near-term headwind reflected in the company’s top-line performance.
  • The insider purchase, while a show of personal investment, represents a finite amount and may not indicate broader insider accumulation.
  • Valuation commentary cited (a PEG ratio of 0.16) is an analytical view and may not capture all company-specific or market risks.

More from Insider Trading

Navitas CFO Executes $123K Share Sale Amid Multiple Corporate Moves Mar 2, 2026 Indie Semiconductor CEO Disposes of $322,846 in INDI Shares; Exercises Options for 186,835 Shares Mar 2, 2026 GigaCloud CEO Disposes $7.07M in Shares Under 10b5-1 Plan Mar 2, 2026 Dolphin Entertainment CEO Makes Small Share Purchase as Company Reports Organic Revenue Gains Mar 2, 2026 Netflix CFO Sells $5.46 Million in Stock After Same-Day Option Exercise Mar 2, 2026